✓ No loaded language, vague sourcing, or framing detected.
The FDA has approved the Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease, marking the fourth such approval in under two years. Roche made the announcement on August 24, 2026.
Our neutral summary
The FDA has approved the Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease, marking the fourth such approval in under two years. Roche made the announcement on August 24, 2026.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
FDA approves new blood test for Alzheimer’s disease
FDA Approves Elecsys Phospho-Tau Blood Test for Alzheimer's Disease